Skip to main content
. 2018 Jun 26;109(8):2599–2610. doi: 10.1111/cas.13652

Figure 2.

Figure 2

Survival curves for nodal Epstein‐Barr virus (EBV)‐negative and EBV‐positive cytotoxic molecule(CM)‐positive peripheral T‐cell lymphoma (CTL) patients (A) and nodal EBV‐negative and EBV‐positive CTL patients with a cut‐off age of 60 y (B)